Lucid Diagnostics annual operating income
2020
2021
2022
2023
2024
2025
Lucid Diagnostics Operating Income Growth & History (LUCD)
Lucid Diagnostics's operating income was −$49.6M for fiscal 2025.
View full Lucid Diagnostics company overviewLucid Diagnostics annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$49.6M | −$3.6M | — |
| 2024 | 2024-12-31 | −$46.1M | $2.4M | — |
| 2023 | 2023-12-31 | −$48.5M | $7.8M | — |
| 2022 | 2022-12-31 | −$56.3M | −$28.8M | — |
| 2021 | 2021-12-31 | −$27.4M | −$19.1M | — |
| 2020 | 2020-12-31 | −$8.3M | — | — |
Lucid Diagnostics quarterly operating income
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$12.8M | −$1.4M | — |
| Q1 2026 | 2026-03-31 | −$12.1M | $373,000 | — |
| Q4 2025 | 2025-12-31 | −$14.0M | −$1.6M | — |
| Q3 2025 | 2025-09-30 | −$11.8M | −$65,000 | — |
| Q2 2025 | 2025-06-30 | −$11.4M | −$192,000 | — |
| Q1 2025 | 2025-03-31 | −$12.5M | −$1.7M | — |
| Q4 2024 | 2024-12-31 | −$12.4M | −$921,000 | — |
| Q3 2024 | 2024-09-30 | −$11.7M | −$566,000 | — |
| Q2 2024 | 2024-06-30 | −$11.2M | $392,000 | — |
| Q1 2024 | 2024-03-31 | −$10.8M | $3.5M | — |
| Q4 2023 | 2023-12-31 | −$11.5M | $3.5M | — |
| Q3 2023 | 2023-09-30 | −$11.1M | $3.2M | — |
| Q2 2023 | 2023-06-30 | −$11.6M | $3.0M | — |
| Q1 2023 | 2023-03-31 | −$14.3M | −$2.0M | — |
| Q4 2022 | 2022-12-31 | −$15.0M | −$3.7M | — |
| Q3 2022 | 2022-09-30 | −$14.4M | −$7.9M | — |
| Q2 2022 | 2022-06-30 | −$14.6M | −$8.6M | — |
| Q1 2022 | 2022-03-31 | −$12.3M | −$8.6M | — |
| Q4 2021 | 2021-12-31 | −$11.2M | — | — |
| Q3 2021 | 2021-09-30 | −$6.5M | −$4.5M | — |
| Q2 2021 | 2021-06-30 | −$6.0M | — | — |
| Q1 2021 | 2021-03-31 | −$3.7M | — | — |
| Q3 2020 | 2020-09-30 | −$2.0M | — | — |
Lucid Diagnostics operating income trends
Over the last five fiscal years, Lucid Diagnostics's operating income decreased from −$8.3M to −$49.6M, a change of −$41.4M. The latest reported quarter, Q2 2026, shows −$12.8M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lucid Diagnostics source filings ↗Community posts
Lucid Diagnostics receives Medicare payments and closes $15 million financing
Lucid Diagnostics ($LUCD) said it has begun receiving Medicare reimbursement for its EsoGuard esophageal cancer test at the established rate of $1,938.01 per test. The announcement advances the reimbursement story from submission of claims ...
